Toll-like receptor 4 Asp299Gly polymorphism and rheumatoid arthritis: A replicative study in three different populations

Inmunologia

Volumn 24, Issue 2, 2005, Pages 205-207

  Orozco, G ^a   Morales, S ^a   Gonzalez Gay M A ^b   Gonzalez Rugeles C I ^c   Ramirez Quintero G ^c   Martín, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

Polymorphism; Rheumatoid arthritis; Toll like receptor 4 gene

Indexed keywords

TOLL LIKE RECEPTOR 4;

ALLELE; ARTICLE; COHORT ANALYSIS; COLOMBIA; DISEASE PREDISPOSITION; GENETIC PREDISPOSITION; GENOTYPE; PATHOGENESIS; POLYMERASE CHAIN REACTION; POPULATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SPAIN;

EID: 23644454648     PISSN: 02139626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-361.
2. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993;32:903-907.
3. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
4. Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunological Reviews 2005;204:27-42.
5. Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, Barrera P et al. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 2004;50:999-1001.
6. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91.
7. Erridge C, Stewart J, Poxton IR. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 2003;197:1787-91.
8. Sánchez E, Orozco G, López-Nevot MA, Jiménez-Alonso J, Martín J. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63:54-57.
9. Lorenz E, Frees KL, Schwartz DA. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques 2001;31:22-4.
10. Kilding R, Akil M, Till S, Amos R, Winfield J, Iles MM et al. A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol 2003;21:340-342.
11. Netea MG, Hijmans A, van Wissen S, Smilde TJ, Trip MD, Kullberg BJ et al. Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur J Clin Invest 2004;34:94-99.
12. Reindl M, Lutterotti A, Ingram J, Schanda K, Gassner C, Deisenhammer F et al. Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens 2003;61:85-88.
13. von Aulock S, Schroder NW, Gueinzius K, Traub S, Hoffmann S, Graf K et al. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis 2003;188:938-943.